Dupilumab treatment normalizes skin barrier function and improves patient-reported outcomes in patients aged 6 to 11 years with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Cork, M. J. [1 ,2 ]
Leung, D. Y. M. [3 ]
Ong, P. [4 ]
Danby, S. G. [1 ]
Ramirez-Gama, M. [3 ]
Garcia, S. [3 ]
Taylor, P. [3 ]
Zahn, J. [5 ]
Praestgaard, A. [6 ]
Bologna, G. [6 ]
Zhang, A. [6 ]
机构：
[1] Univ Sheffield, Sheffield Dermatol Res, Sheffield, England
[2] Sheffield Childrens Hosp, Sheffield, England
[3] Natl Jewish Hlth, Denver, CO USA
[4] Univ Southern Calif, Childrens Hosp Los Angeles, Los Angeles, CA USA
[5] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[6] Sanofi, Cambridge, MA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
55
引用
收藏
页码：S342 / S342
页数：1
相关论文
共 50 条
  • [31] Effect of abrocitinib vs dupilumab and placebo on patient-reported outcomes (PROs) in moderate-to-severe atopic dermatitis (AD) in JADE COMPARE
    Yosipovitch, Gil
    Thyssen, Jacob P.
    Paul, Carle
    Kwatra, Shawn G.
    Chu, Chia-Yu
    Rojo, Ricardo
    Valdez, Hernan
    Feeney, Claire
    Zhang, Fan
    Myers, Daniela E.
    DiBonaventura, Marco
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB133 - AB133
  • [32] Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis
    Lio, Peter A.
    Armstrong, April
    Gutermuth, Jan
    Nosbaum, Audrey
    Sofen, Howard
    Gil, Esther Garcia
    Casillas, Marta
    Chen, Sherry
    Sun, Luna
    Pierce, Evangeline
    Elmaraghy, Hany
    Dawson, Zach
    Torres, Tiago
    DERMATOLOGY AND THERAPY, 2024, 14 (07) : 1929 - 1943
  • [33] Dupilumab treatment reduces skin pain in infants and young children aged 6 months-5 years with moderate-to-severe atopic dermatitis
    Paller, Amy S.
    Silverberg, Jonathan I.
    Siegfried, Elaine C.
    Gonzalez, Mercedes E.
    Schneider, Lynda C.
    Sidbury, Robert
    Zhang, Haixin
    Prescilla, Randy
    Wang, Zhixiao
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E101 - E101
  • [34] Treatment satisfaction in patients receiving dupilumab for moderate-to-severe atopic dermatitis
    Lans, A.
    Van der Schaft, J.
    Bakker, D.
    Ariens, L.
    Thijs, J. H.
    De Bruin-Weller, M. S.
    Balak, D. M. W.
    ALLERGY, 2019, 74 : 82 - 82
  • [35] Dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis
    Siegfried, Elaine C.
    Cork, Michael J.
    Arkwright, Peter D.
    Wollenberg, Andreas
    Eichenfield, Lawrence F.
    Ramien, Michele
    Khokhar, Faisal A.
    Chen, Zhen
    Zhang, Annie
    Cyr, Sonya L.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [36] Dupilumab treatment restores skin barrier function measured by transepidermal water loss in adults and adolescents with moderate-to-severe atopic dermatitis
    Bissonnette, R.
    Ramirez-Gama, M.
    Garcia, S.
    Taylor, P.
    Praestgaard, A.
    Levit, N. A.
    Rossi, A. B.
    Zhang, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E156 - E156
  • [37] Dupilumab treatment improves health-related quality of life in children aged 6 months-5 years with moderate-to-severe atopic dermatitis
    Paller, Amy S.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Cork, Michael J.
    Wollenberg, Andreas
    Arkwright, Peter D.
    Zhang, Haixin
    Wang, Zhixiao
    Rodriguez Marco, Ainara
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E104 - E105
  • [38] Ophthalmological characteristics and treatment outcomes of conjunctivitis in patients receiving dupilumab for moderate-to-severe atopic dermatitis
    Lans, A.
    Van Luijk, C. M.
    Bakker, D. S.
    Ariens, L. F. M.
    Thijs, J. L.
    Van der Schaft, J.
    De Boer, J. H.
    Knol, E. F.
    De Bruin-Weller, M. S.
    Balak, D. M. W.
    ALLERGY, 2019, 74 : 714 - 714
  • [39] DUPILUMAB TREATMENT IMPROVES HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AGED 6 MONTHS TO 5 YEARS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS AND THEIR CAREGIVERS
    Paller, Amy S.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Cork, Michael J.
    Wollenberg, Andreas
    Arkwright, Peter D.
    Zhang, Haixin
    Wang, Zhixiao
    Marco, Ainara Rodriguez
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 49 - 49
  • [40] Benefits of treatment with dupilumab for children aged 6-11 years with severe atopic dermatitis
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (02) : E39 - E39
12345